Breast cancer cell response to calcitonin: Modulation by growth- regulating agents

European Journal of Pharmacology

Volumn 344, Issue 2-3, 1998, Pages 279-286

  Lacroix, Marc ^a   Siwek, Brigitte ^a   Body, Jean Jacques ^a  

^a Lab d'Invest Clin d'Oncol E   (Belgium)

Author keywords

Breast cancer; Calcitonin; CAMP; Cell growth; Estrogen; Tamoxifen

Indexed keywords

ADENYLATE CYCLASE; ANTISENSE OLIGONUCLEOTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN; CALCITONIN RECEPTOR; CALCITRIOL; CYCLIC AMP; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FORSKOLIN; GROWTH INHIBITOR; ISOPRENALINE; MITOGENIC AGENT; SALCATONIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TAMOXIFEN;

ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PLEURA EFFUSION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

EID: 0032485395     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01578-1     Document Type: Article

References (32)

1. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cyclic AMP signaling pathway: Stimulation of adenylate cyclase and cyclic AMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA. 91:1994;8517-8521.
2. Azria, M., 1989. The Calcitonins: Physiology and Pharmacology. Karger, Basel.
3. Body J.J., Glibert F., Nejai S., Fernandez G., VanLangendonck A., Borkowski A. Calcitonin receptors on circulating normal human lymphocytes. J. Clin. Endocrinol. Metab. 71:1990;675-681.
4. Carpenter G., Cohen S. Epidermal growth factor. J. Biol. Chem. 265:1990;7709-7712.
5. Chakraborty M., Chatterjee D., Kellokumpu S., Rasmussen H., Baron R. Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. Science. 251:1991;1078-1082.
6. Chien C.-H., Wang F.-F., Hamilton T.C. Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol. Cell. Endocrinol. 99:1994;11-19.
7. Cho-Chung Y.S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy. Cancer Res. 50:1990;7093-7100.
8. 3 in human cancer cells. In: Kumar, R. (Ed.), Vitamin D Metabolism: Basic and Clinical Aspects. Martinus Nijhoff, The Hague, pp. 365-382.
9. Emorine L.J., Marullo S., Briend-Sutren M.M., Patey G., Tate K., Delavier-Klutchko C., Donny Strosberg A. Molecular characterization of the human beta 3-adrenergic receptor. Science. 245:1989;1118-1121.
10. Evan G.I., Littlewood T.D. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:1993;44-49.
11. Fentiman I.S., Duhig T., Griffiths A.B., Taylor-Papadimitriou J. Cyclic AMP inhibits the growth of human breast cancer cells in defined medium. Mol. Biol. Med. 2:1984;81-88.
12. Findlay D.M., Michelangeli V.P., Eisman J.A., Frampton R.J., Moseley J.M., MacIntyre I., Whitehead R., Martin T.J. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res. 40:1980;4764-4767.
13. Fortunati N., Fissore F., Fazzari A., Becchis M., Comba A., Catalano M.G., Berta L., Frairia R. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A. Endocrinology. 137:1996;686-692.
14. Gilman A.G. G proteins: Transducers of receptor-generated signals. Annu. Rev. Biochem. 56:1987;615-649.
15. Guilbaud N.F., Gas N., Dupont M.A., Valette A. Effect of differentiation-inducing agents on maturation of human breast cancer cells. J. Cell. Physiol. 145:1990;162-172.
16. Iyengar R. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J. 7:1993;768-775.
17. Kuestner R.E., Elrod R.D., Grant F.J., Hagen F.S., Kuijper J.L., Matthewes S.L., O'Hara P.J., Sheppard P.O., Stroop S.D., Thompson D.L., Whitmore T.E., Findlay D.M., Houssami S., Sexton P.M., Moore E.E. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol. Pharmacol. 46:1994;246-255.
18. Lacroix M., Body J.J. Regulation of c-fos and c-jun expression by calcitonin in human breast cancer cells. Calcified Tissue Int. 60:1997;513-519.
19. Lacroix M., Siwek B., Body J.J. Effects of secretory products of breast cancer cells on osteoblast-like cells. Breast Cancer Res. Treat. 38:1996;209-216.
20. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36:1976;4595-4601.
21. Maas R.A., Bruning P.F., Top B., Breedijk A.J., Peterse H.L. Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: Potential early indicators of treatment response. Cancer Lett. 97:1995;107-116.
22. Marchetti B., Fortier M., Poyet P., Follea N., Pelletier G., Labrie F. Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: Characterization, distribution and coupling to adenylate cyclase. Endocrinology. 126:1990;565-574.
23. Monroe J.J., Tashjian A.H. Jr. Pretreatment with 17 beta-estradiol attenuates basal- and parathyroid hormone-stimulated membrane adenylyl cyclase activity in human osteoblast-like SaOS-2 cells. Biochem. Biophys. Res. Commun. 225:1996;320-325.
24. Musgrove E.A., Hamilton J.A., Lee C.S.L., Sweeney K.J.E., Watts C.K.W., Sutherland R.L. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:1993;3577-3587.
25. Reddel R.R., Sutherland R.L. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res. 47:1987;5323-5329.
26. 3 modulation of mammary tumor growth in vitro and in vivo. Breast Cancer Res. Treat. 27:1993;69-81.
27. Seamon K., Daly J.W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256:1981;9799-9801.
28. Sorger T., Germinario R.J. A direct solubilization procedure for the determination of DNA and protein in cultured fibroblast monolayers. Anal. Biochem. 131:1983;254-256.
29. i1-2 proteins in pancreatic acinar membranes. Biochem. J. 316:1996;87-91.
30. Taylor I.W., Hodson P.J., Green M.D., Sutherland R.L. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res. 43:1983;4007-4010.
31. Wollman R., Yahalom J., Maxy R., Pinto J., Fuks Z. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;91-98.
32. Zaidi M., Datta H.K., Moonga B.S., MacIntyre I. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. J. Endocrinol. 126:1990;473-481.